Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Elder Pharmaceuticals discovers new glucose-lowering agents

Aug. 9, 2010

BPR-0912 exhibits antiobesity effects in vivo

Aug. 9, 2010

Takeda presents new glucokinase activators

Aug. 6, 2010

Preclinical study implicates GPR55 in regulation of osteoclast number and function

Aug. 6, 2010

CANOE trial data support use of Avandamet to prevent type 2 diabetes

Aug. 6, 2010

New FPS inhibitors discovered at Novartis

Aug. 6, 2010

Santhera discloses new MC4 receptor antagonists

Aug. 6, 2010

Mipomersen lowers LDL-cholesterol in two phase III trials

Aug. 5, 2010

TM-38837 shows favorable safety and pharmacokinetics in healthy subjects

Aug. 5, 2010

Diamyd receives upfront payment from OMJP under Diamyd collaboration

Aug. 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...